Search Results - Dvergsten, Chris

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

    Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia by Walling, David, Marder, Stephen R, Kane, John, Fleischhacker, W Wolfgang, Keefe, Richard S E, Hosford, David A, Dvergsten, Chris, Segreti, Anthony C, Beaver, Jessica S, Toler, Steven M, Jett, John E, Dunbar, Geoffrey C

    Published in Schizophrenia bulletin
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes

    Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes by Klein, Klara R., Boeder, Schafer C., Freeman, Jennifer L. R., Dunn, Imogene, Dvergsten, Chris, Madduri, Supradeep, Giovannetti, Erin R., Valcarce, Carmen, Buse, John B., Pettus, Jeremy H.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study

    Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study by Gabrail, Nashat Y., Dvergsten, Chris, Ahdieh, Harry

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: